Metoclopramid Terapia

Metoclopramide Hydrochloride Monohydrate, the active ingredient in Metoclopramid Terapia, is a dopamine antagonist (antiemetic) presented as an oral tablet for oral use. It is used to treat nausea, vomiting, gastroparesis, and related gastrointestinal disorders in adult patients. GNH USA supplies Metoclopramid Terapia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide acts on the gastrointestinal and central nervous systems to relieve symptoms associated with several disorders. - Nausea and vomiting: reduces acute and delayed episodes caused by surgery, medication, or other triggers. - Gastroparesis: improves gastric emptying and alleviates related discomfort. - Gastro‑oesophageal reflux disease (GERD): decreases reflux episodes by enhancing motility. - Chemotherapy‑induced nausea: prevents or lessens nausea associated with cytotoxic agents.

Metoclopramide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Fatigue: general lack of energy. - Diarrhea: loose or watery stools. - Restlessness: feeling uneasy or unable to stay still. - Headache: mild to moderate head pain. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Extrapyramidal symptoms: muscle rigidity, tremor, or involuntary movements. - Tardive dyskinesia: persistent involuntary facial movements with long‑term use. - Neuroleptic malignant syndrome: rare, life‑threatening reaction with fever and muscle rigidity. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Cardiac arrhythmias: irregular heartbeats in susceptible individuals.

Metoclopramide should be used with caution in specific clinical situations. - Pregnancy: avoid unless clearly needed; limited safety data are available. - Breastfeeding: consider potential drug exposure to the infant. - Elderly patients: monitor for increased risk of extrapyramidal effects. - Renal impairment: dose adjustment may be required. - History of movement disorders: assess risk of worsening symptoms. - Store below 25°C: keep in the original pack, protect from moisture.

Metoclopramide can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): additive risk of extrapyramidal symptoms. - MAO inhibitors: increased risk of hypertensive crisis. - CNS depressants (e.g., opioids, benzodiazepines): enhanced sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - CYP2D6 substrates (e.g., metoprolol): possible altered plasma levels. - Anticholinergic agents: may reduce pro‑kinetic effect. - Antihistamines: potential increase in drowsiness. - Digoxin: monitor for altered cardiac effects.